[Current status of hormone therapy during the menopausal transition and post-menopause].
Starting from prospective clinical studies that have evaluated its benefits and risks, hormone replacement therapy in menopause women has been reassessed in its indications in the last four years. In October, 2004 a Latinamerican Experts Consensus was carried out, such report with some modifications is presented in this publication. The conclusions the experts reached were the following: 1) Hormone Therapy is the gold standard for the control of moderate to severe vasomotor symptoms; 2) this therapy must be indicated in an individual manner and only in symptomatic women in which the benefit is greater than the risk; 3) the least effective dose must be used; 4) it must be used neither for cardiovascular prevention, osteoporosis, colon cancer nor for mental disorder; 5) the patient must be informed about the benefits and risks.
Figueroa-Casas
Pedro R
PR
Universidad Nacional de Rosario.
D005260:Female; D020249:Hormone Replacement Therapy / Q000592:standards*; D006801:Humans; D047648:Perimenopause; D017698:Postmenopause; D017410:Practice Guidelines as Topic